Hell, gotta get into the 'over the top' headlines but seriously - if you aren't holding some of this stock in your portfolio you aren't entirely serious.
On a more immediate note the signs have been there for some time with the 'roadblocks' built at $3.00 and then at $2.90 that the corporate 'fisherman' have been herding the minnow shareholders and shorttermers out of their stock.
Gutfeeling but CST might be about to have a run up.
They know time is on their side but CST's management are working diligently away at marketing one of the few Australian success stories of the biotech world that will hit the bigtime and still be owned by an Australian company.
Add to My Watchlist
What is My Watchlist?
